CIMETIDINE SULFOXIDATION IN SMALL-INTESTINAL MICROSOMES

Citation
Xd. Lu et al., CIMETIDINE SULFOXIDATION IN SMALL-INTESTINAL MICROSOMES, Drug metabolism and disposition, 26(9), 1998, pp. 940-942
Citations number
19
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
00909556
Volume
26
Issue
9
Year of publication
1998
Pages
940 - 942
Database
ISI
SICI code
0090-9556(1998)26:9<940:CSISM>2.0.ZU;2-K
Abstract
In previous studies, sulfoxide metabolite was observed in animal and h uman intestinal perfusions of cimetidine and other H-2-antagonists in vivo. L-Methionine, imipramine, and the anionic exchange inhibitor dii sothiocyanostilbene-2,2'-disulfonic acid reduced metabolite appearance . A sequence of follow-up studies is underway, for the purpose of asse ssing the contributions of drug metabolism and drug and metabolite tra nsport to variable drug absorption. In this regard, drug-drug and drug -nutrient interactions represent a primary focus of this research. The S-oxidation of cimetidine in mammalian small intestinal microsomes wa s studied from three different species and two intestinal regions. Bas ed on preparation activity and tissue availability, the relative contr ibutions of flavin-containing monooxygenases and cytochrome P450 enzym es to cimetidine sulfoxidation were evaluated in rabbit jejunal micros omes. Additional inhibitor studies were carried out to evaluate the ro le of microsomal cimetidine sulfoxidation in the previous in vivo obse rvations.